Navigation Links
Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management
Date:7/31/2014

MUMBAI, India, July 31, 2014 /PRNewswire/ --

Cipla Europe NV ("Cipla") and BioQuiddity Inc. announced today that they recently entered into a commercial collaboration, covering the territory of the European Union and certain other European countries, for BioQuiddity's OneDose ReadyfusOR™ in regional anesthetic applications for post-surgical pain management. Cipla intends to launch the CE Marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this year. The ready-to-use infusion systems are non-electric, ambulatory, and should enable seamless transition between sites of care.

     (Logo: http://photos.prnewswire.com/prnh/20140731/700144)

"Cipla is an excellent strategic partner for BioQuiddity and our pre-filled ready-to-use post-surgical pain product candidates," said Mr. Joshua Kriesel, President and CEO. "Cipla's strong commercial record puts them in an outstanding position to detail the OneDose ReadyfusOR's safety, sterility, and ease of use value proposition objectives."

"We are thrilled to be BioQuiddity's European commercial partner for the OneDose ReadyfusOR," said Mr. Frank Pieters, Head Cipla Europe. "Cipla believes that this post-surgical pain product candidate presents a unique opportunity to provide an easy to use, well-tolerated, and efficient regional anesthesia system that could make savings for healthcare providers and patients."

About Cipla Limited 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.  Our portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.  Cipla's turnover in 2013-14 was 1.7 billion USD.

Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines.  Cipla's emphasis on access for patients was recognized globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than one dollar a day and thereby treating many millions of patients since 2001.  

Cipla's research and development focuses on developing innovative products and drug delivery systems and has given India and the world many 'firsts', for instance Triomune. In a tightly regulated environment, the company's manufacturing facilities have approvals from all the main regulators including USFDA, UKMHRA, WHO, MCC, ANVISA, and PMDA which means the company provides one universal standard both domestically and internationally.

About Cipla Europe NV 

Cipla Europe NV is a 100% subsidiary of Cipla Limited.

About BioQuiddity Inc. 

BioQuiddity is a privately held corporation located in San Francisco, California. The Company is focused on addressing some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQuiddity's ultimate objective is to provide value to the healthcare community by playing a vital role in containing costs and improving quality via the Company's proprietary unit-dose infusion systems. The Company is ISO13485 certified. West Pharmaceutical Services, an existing strategic partner of BioQuiddity's, will be assembling the OneDose ReadyfusOR.

Media Contact:
Charlotte Chunawala
Corporate Communications
Mob: +91-7506257377
Email: charlotte.chunawala@cipla.com

Jaisingh Balakrishnan
Corporate Communications
Mob: +91-9833836185
Email: jaisingh.krishnan@cipla.com


'/>"/>
SOURCE Cipla and BioQuiddity
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Cipla Medpro Achieves "Worry Free" Supply Chain Planning with Help from ToolsGroup
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
4. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2019)... ... ... Based on data for the first eight months of the year, 2019 is on ... August 31, 7,786 deceased donors have provided 23,797 organs for transplant according to the ... Association of Organ Procurement Organizations (AOPO) projects 2019 could see an additional 1,000 donors ...
(Date:10/10/2019)... PLEASANTVILLE, N.Y. (PRWEB) , ... October 10, 2019 ... ... Ping Pong Parkinson Championships , 2019 ITTF Parkinson World Table Tennis Championships, ... unable to play music and perform in public. So, he sought to find ...
(Date:10/9/2019)... ... October 09, 2019 , ... The 11th annual ... Yoga Science and AMI Meditation for the relief and prevention of physician burnout. ... October 22-26, 2019 at the Cranwell Resort and Spa in Lenox, Massachusetts, is ...
Breaking Medicine Technology:
(Date:10/10/2019)... SAN MATEO, Calif. (PRWEB) , ... October 10, 2019 , ... ... 2019 Senior Living Report on the Best and Worst Places for Seniors to Live. ... housing options, community engagement, transportation, quality of life and workforce development. , According ...
(Date:10/8/2019)... HUNTINGTON BEACH, Calif. (PRWEB) , ... October 08, 2019 , ... ... CA. , "We are happy to announce the expansion of our services to better ... "We had the opportunity over this last year to see the extraordinary impact this ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... in West Hartford, CT, help patients with missing teeth restore their smiles with ... team of oral surgeons relies on advanced i-CAT® 3D Cone Beam CT imaging, ...
(Date:10/8/2019)... ... October 08, 2019 , ... At the ... 4medica® President Gregg Church will inform conference attendees how the 4medica ... management-by starting with the right, clean patient data. The single platform interfaces to ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... Healthcare to seamlessly integrate skills and procedures content from Dynamic Health™ ... help nurses and allied health professionals master critical skills. MCN provides custom policy ...
Breaking Medicine News(10 mins):